19-12015398-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001308348.2(ZNF433):c.1460C>T(p.Pro487Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000285 in 1,613,988 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001308348.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF433 | NM_001308348.2 | c.1460C>T | p.Pro487Leu | missense_variant | 4/4 | ENST00000550507.7 | NP_001295277.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF433 | ENST00000550507.7 | c.1460C>T | p.Pro487Leu | missense_variant | 4/4 | 2 | NM_001308348.2 | ENSP00000448099.2 | ||
ENSG00000286098 | ENST00000652448.1 | c.-94+13576G>A | intron_variant | ENSP00000498410.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152130Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000680 AC: 17AN: 250130Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135666
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461858Hom.: 0 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 727222
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152130Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2024 | The c.1469C>T (p.P490L) alteration is located in exon 4 (coding exon 4) of the ZNF433 gene. This alteration results from a C to T substitution at nucleotide position 1469, causing the proline (P) at amino acid position 490 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at